Novo Nordisk

Type
Reshoring
Country
Denmark
Reshoring from
Switzerland
Reshored business function
Administration
Region
Danmark; Hovedstaden; Byen København
Location of affected unit(s)
Copenhagen
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations
55 jobs
Number of planned job creations
Job creation
Announcement Date
22 December 2016
Employment effect (start)
1 December 2016
Foreseen end date
1 January 2017

Description

Novo Nordisk is a Danish pharmaceutical company. The firm has decided to move its European headquarters from Zürich (Switzerland) to the homeland, Copenhagen (Denmark). Through the relocation 55 positions are created in Denmark. Among these, 20 employees will be relocated to Switzerland, having agreed to move to Denmark. This means that the firm hired 35 new employees. The new headquarters have been opened on 2 January 2017.

Sources

Citation

Eurofound (2016), Novo Nordisk, Reshoring in Denmark, factsheet number 144, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/144.